Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

ClinicalTrials.gov ID: NCT07449936

Public ClinicalTrials.gov record NCT07449936. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 7, 2026, 12:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Prospective, Randomized, Double-Masked, Parallel-Group Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), Compared to Aflibercept (2 mg) in Participants With Diabetic Macular Edema (DME)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.

Study identification

NCT ID
NCT07449936
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
EyePoint Pharmaceuticals, Inc.
Industry
Enrollment
240 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 15, 2026
Primary completion
Sep 30, 2027
Completion
Sep 30, 2028
Last update posted
Sep 2, 2026

2026 – 2028

United States locations

U.S. sites
53
U.S. states
23
U.S. cities
52
Facility City State ZIP Site status
California Retina Consultants Bakersfield California 93309
The Retina Partners Encino California 91436
Global Research Management, Inc. Glendale California 91204
Northern California Retina Vitreous Associates Medical Group INC. Mountain View California 94040
Retina Consultants of San Diego Poway California 92064
California Eye Specialists Medical Group, Inc. Redlands California 92373
Retinal Consultants Medical Group - Parkcenter Drive Sacramento California 95825
Retinal Consultants Medical Group Sacramento California 95841
Retina Consultants of Southern Colorado Colorado Springs Colorado 80909
Colorado Retina Associates Lakewood Colorado 80228
Advanced Research LLC Sibia Eye Institute Boynton Beach Florida 33437
Advance Medical Research Group, Inc Deerfield Beach Florida 33064
Eye Associates of Pinellas Pinellas Park Florida 33782
Retina Vitreous Associates of Florida - Saint Petersburg St. Petersburg Florida 33711
Southern Vitreoretinal Associates Tallahassee Florida 32308
Retina Specialists of Tampa Wesley Chapel Florida 33544
Georgia Retina Marietta Georgia 30060
Retina Consultants of Hawaii ‘Aiea Hawaii 96701
Red River Research Partners Plainfield Illinois 60586
Midwest Eye Institute - Carmel Carmel Indiana 11220
Haik Humble Eye Center West Monroe Louisiana 71291
Johns Hopkins Medicine - The Johns Hopkins Hospital Campus - Wilmer Eye Institute Baltimore Maryland 21287
Retina Group of Washington Chevy Chase Maryland 20815
Cumberland Valley Retina Consultants Hagerstown Maryland 21740
Retina Specialists - Towson Towson Maryland 21204
New England Retina Consultants Springfield Massachusetts 01107
Retina Associates of Michigan Grand Blanc Michigan 48439
Foundation for Vision Research Grand Rapids Michigan 49546
Sierra Eye Associates Reno Nevada 89502
NJRetina Care Center - Teaneck Teaneck New Jersey 07666
NJ Retina - Toms River Toms River New Jersey 08755
Retina Associates of Western New York Rochester New York 14620
VRCNY/Long Island Vitreoretinal Consultants Westbury New York 11590
Asheville Eye Associates - Regional Medical Park Asheville North Carolina 28803
Cape Fear Retinal Associates, PC Wilmington North Carolina 28401
Piedmont Retina Specialists, P.A. - Winston-Salem Office Winston-Salem North Carolina 27103
Tulsa Retina Consultant Tulsa Oklahoma 74114
Erie Retina Research Erie Pennsylvania 16507
Charleston Neuroscience Institute - Beaufort Beaufort South Carolina 29902
Retina Consultants of Carolina P.A Greenville South Carolina 29605
Tennessee Retina Nashville Tennessee 37203
Retina Research Institute of Texas Integrated Clinical Research Abilene Texas 79606
Texas Retina Associates Dallas Texas 75231
Mt. Olympus Medical Research Houston Texas 77479
Retina Consultants of Texas Katy Texas 77494
Texas Retina Associates Plano Texas 75075
Retina Consultants of Texas Schertz Texas 78154
Tyler Retina Consultants Tyler Texas 75703
Retina Associates of Utah Salt Lake City Utah 84107
Salt Lake Retina West Jordan Utah 84088
Piedmont Eye Center Lynchburg Virginia 24502
Virginia Retina Center Warrenton Virginia 20186
Northeast Wisconsin Retina Associates Appleton Wisconsin 54914

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07449936, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 2, 2026 · Synced Sep 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07449936 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →